带有骨质细胞样巨细胞的泌尿腺癌:扩大了免疫组织化学和分子特征
Carol N Rizkalla1, Maria Tretiakova1, Carlos J Suarez2
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
American journal of clinical pathology
|June 13, 2025
概括
尿道富有骨质细胞的不分化癌 (UCOGC) 是一种罕见的瘤. 这项研究发现UCOGC具有独特的特征,支持其被归类为尿路细胞癌的独特亚型.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 泌尿生殖系统的癌症
背景情况:
- 尿道富有骨质细胞的不分化癌 (UCOGC) 是一种罕见的瘤.
- 目前被归类为差分泌尿道癌.
- 它的独特起源和分类需要进一步调查.
研究的目的:
- 评估UCOGC的临床病理学,免疫类型和分子特征.
- 为了描述UCOGC的起源.
- 支持将UCOGC分类为一个独特的亚型.
主要方法:
- 通过免疫组织化学和现场杂交研究了14种UCOGC.
- 将UCOGC与带热囊细胞分化和巨细胞尿癌的尿癌进行比较.
- 在4个UCOGC上进行了下一代测序.
主要成果:
- 在UCOGC中的单核细胞显示了CD68,CD163,SATB2,cathepsin K和CSF1.1的高表达.
- 巨细胞表达了高的CD68,PU.1和cathepsin K,但低的CD163,SATB2和CSF1.
- 下一代测序揭示了与常规泌尿器癌相一致的突变.
结论:
- 独特的双相形态和免疫表型表明UCOGC的泌尿器官起源.
- 分子发现与传统的泌尿道癌相一致.
- UCOGC证明了将其归类为一个独特的亚型.
关键词:
在CSF1 ISH中.不同化的差异化差异化.免疫组织化学 免疫组织化学一个分子的分子分子分子.骨质细胞类似的骨质细胞.富含骨质细胞的骨质细胞差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异化差异小型类型 亚型 类型尿路细胞癌是什么意思更多相关视频
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
8.9K
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
10.1K
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
